Medicine & Life Sciences
Acute Myeloid Leukemia
100%
Cytarabine
35%
Gemtuzumab
30%
Survival
22%
Biomedical Research
19%
Recurrence
19%
Pelvic Pain
19%
Clofarabine
16%
fms-Like Tyrosine Kinase 3
15%
Drug Therapy
14%
Induction Chemotherapy
13%
Chronic Pain
13%
Cytogenetics
12%
Randomized Controlled Trials
12%
Transplantation
11%
Therapeutics
11%
Daunorubicin
11%
Mutation
11%
Core Binding Factors
10%
Random Allocation
10%
Pain
10%
Residual Neoplasm
9%
Myelodysplastic Syndromes
9%
Protein-Tyrosine Kinases
8%
tipifarnib
7%
3-tyrosine
7%
Meta-Analysis
7%
Clinical Trials
7%
Odds Ratio
7%
Stem Cells
7%
Confidence Intervals
6%
Azacitidine
6%
Rectal Prolapse
6%
Polymerase Chain Reaction
6%
Donepezil
6%
Xeroderma Pigmentosum
6%
Polyglactin 910
5%
Leukemia
5%
Hypopituitarism
5%
Acute Promyelocytic Leukemia
5%
Streptococcus agalactiae
5%
Hydroxyurea
5%
Dyspareunia
5%
Adjuvant Radiotherapy
5%
Trastuzumab
5%
Premature Mortality
5%
Tretinoin
5%
Midwifery
5%